D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 87,300
+2,400 (2.83%)
Dec 10, 2025, 3:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 3.69 trillion as of December 10, 2025. Its market cap has increased by 784.20% in one year.
Market Cap
3.69T
Enterprise Value
3.65T
Revenue
8.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
87,300.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 3.69T, an increase of 871.33%. That is a compound annual growth rate of 312.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 3.69T | 617.82% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.41T |
| Celltrion | 40.94T |
| ALTEOGEN | 24.49T |
| SK Biopharmaceuticals | 10.44T |
| ABL Bio | 10.30T |
| Yuhan | 8.67T |
| LigaChem Biosciences | 6.66T |
| HLB Co., Ltd. | 6.53T |